Wednesday, 30 January 2019

Amgen falls 3% after 2019 outlook falls short

Amgen's results follow similar news from Pfizer earlier Tuesday, which also posted strong fourth-quarter results but issued weak 2019 guidance.

from Health and Science https://cnb.cx/2DFi9OA
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)